Neurotrope (SNPX) Company Long-Term Loans and Borrowings

Official company branding of Neurotrope (SNPX)

The Synaptogenix, Inc. (SNPX) price chart on the GURU.Markets platform demonstrates long-term debt amounting to 0.00. This biotech startup is researching methods to combat Alzheimer's, planning to generate future profits through licensing royalties to partners. Currently, the micro-cap is fighting for survival and patent extensions, lacking market weight against industry behemoths. The business currently relies on grants while developing drugs for the regeneration of neural connections.

SNPX (Synaptogenix) Company Long-Term Debt history from 07/04/2022 to 05/02/2026

SNPX (Neurotrope): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price synaptogen.com|SNPX - Price Target Chart
- market capitalization data:
Market Value Synaptogenix|SNPX - Total Company Value
- book capitalization data:
Net Asset Value per Share Synaptogenix|SNPX - Company Book Value|Market Capitalization to Book Value synaptogen.com|SNPX - Cumulative Company Assets
- debt and liquidity data:
Debt to Capital Synaptogenix, Inc.|SNPX - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Synaptogenix, Inc|SNPX - Company Aggregate Debts|Debts to Book Capitalization Synaptogenix|SNPX - Company Long-Term Debt|Current Liabilities Synaptogenix
Summary company analytics:synaptogen.com (SNPX)
Manufactured products of synaptogen.com

When constructing a long-term portfolio, it is critical to assess the stability of the issuer's capital structure. This indicator aggregates all credit obligations with maturities exceeding one year, measuring the level of debt load on the business. For Synaptogenix, Inc. (SNPX), this determines the financial resources available for the development of a unique Alzheimer's disease therapy. A potential monopoly in the treatment of cognitive impairment must justify the borrowings. Evaluate the change in the issuer's long-term liabilities to analyze the company's solvency.

Main competitors

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|ACAD (ACADIA Corp) - Long-Term Debt|XENE: Company Long-Term Debt|Long-Term Debt Volume vikingtherapeutics.com (VKTX)|Supernus - Company Long-Term Liabilities|Long-Term Debt CPRX (Catalyst Pharma)|DNLI - Company Long-Term Debt|Company Long-Term Indebtedness Harmony Corp HRMY|Biohaven Ltd. - Company Long-Term Debts|AMLX: Company Long-Term Debts|Company Long-Term Debt Trevi Therapeutics, Inc. (TRVI)|Long-Term Liabilities Praxis Precision Medicines Inc|Anavex Corp (AVXL) - Company Long-Term Liabilities|Amount of Long-Term Liabilities CBLL|Prothena - Company Long-Term Debt|Long-Term Debt alector.com (ALEC)|ANNX (Annexon) - Company Long-Term Debts|Long-Term Indebtedness Omeros Corp OMER|NGNE (Neurogene Corp) - Company Long-Term Debts|ACIU: Long-Term Debt|Company Long-Term Debt Voyager Therapeutics|neumoratx.com (NMRA) - Company Long-Term Indebtedness|SCLX: Company Long-Term Debts|Long-Term Debt Volume Tevogen Bio Holdings Inc. (TVGN)|Company Long-Term Liabilities Alpha Cognition ACOG|Company Long-Term Indebtedness cogrx.com CGTX|Company Long-Term Liabilities Inhibikase Therapeutics|Company Long-Term Loans and Borrowings cassavasciences.com SAVA|Company Long-Term Debts ASRT (Assertio Therapeutics)|COYA: Long-Term Debt Volume|Company Long-Term Debt vistagen.com|Ovid Therapeutics (OVID) - Company Long-Term Indebtedness|Company Long-Term Debts ABOS|Company Long-Term Liabilities cervomed.com (CRVO)|ATHE (Alterity Therapeutics) - Company Long-Term Liabilities|Long-Term Debt Volume CLNN (clene.com)|Company Long-Term Debt PEPG|jupiterneurosciences.com - Long-Term Debt Volume|Relmada Therapeutics (RLMD) - Company Long-Term Debt|ANVS: Company Long-Term Indebtedness|Company Long-Term Debt gracetx.com (GRCE)|Long-Term Liabilities Firefly Neuroscience, Inc.|Company Long-Term Liabilities ANEW Medical (KLTO)|Company Long-Term Indebtedness NRSN|Company Long-Term Debt Reviva Pharmaceuticals RVPH|Company Long-Term Indebtedness metaviatx.com (MTVA)|NRXS: Company Long-Term Debts|HSDT - Long-Term Debt|Passage Bio Corp - Company Long-Term Liabilities|NEUP: Company Long-Term Debts|Company Long-Term Debt Minerva Neurosciences NERV|ATHA (athira.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt ADXN (Addex Therapeutics Ltd)|Long-Term Debt ALZN|CYCN (Cyclerion Therapeutics) - Company Long-Term Debt|Long-Term Debt Volume protagenic.com PTIX|KTTA: Company Long-Term Liabilities|Cortigent Inc - Long-Term Debt|Avenue Therapeutics, Inc. (ATXI) - Company Long-Term Debt|BCLI - Company Long-Term Indebtedness|CARA: Company Long-Term Debts|CHRO (Chromocell) - Company Long-Term Debts|Company Long-Term Debt Eliem Therapeutics, Inc. ELYM|Long-Term Liabilities Intra-Cellular (ITCI)|Company Long-Term Liabilities Longboard Pharmaceuticals, Inc.|Amount of Long-Term Liabilities MRNS (Marinus Pharmaceuticals Inc)|NKGN: Company Long-Term Debt|Long-Term Debt NeuroBo Pharma NRBO|Company Long-Term Debts SAGE|TRVN - Long-Term Indebtedness|Company Long-Term Debts VIGL|WENA (Anew Medical Inc.) - Long-Term Debt|Company Long-Term Debt Cerevel (CERE)